Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia

Standard

Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia. / Rivkin, Mila; Simerzin, Alina; Zorde-Khvalevsky, Elina; Chai, Chofit; Yuval, Jonathan B; Rosenberg, Nofar; Harari-Steinfeld, Rona; Schneider, Ronen; Amir, Gail; Condiotti, Reba; Heikenwalder, Mathias; Weber, Achim; Schramm, Christoph; Wege, Henning; Kluwe, Johannes; Galun, Eithan; Giladi, Hilla.

In: GASTROENTEROLOGY, Vol. 151, No. 5, 11.2016, p. 999-1010.e3.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rivkin, M, Simerzin, A, Zorde-Khvalevsky, E, Chai, C, Yuval, JB, Rosenberg, N, Harari-Steinfeld, R, Schneider, R, Amir, G, Condiotti, R, Heikenwalder, M, Weber, A, Schramm, C, Wege, H, Kluwe, J, Galun, E & Giladi, H 2016, 'Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia', GASTROENTEROLOGY, vol. 151, no. 5, pp. 999-1010.e3. https://doi.org/10.1053/j.gastro.2016.07.031

APA

Rivkin, M., Simerzin, A., Zorde-Khvalevsky, E., Chai, C., Yuval, J. B., Rosenberg, N., Harari-Steinfeld, R., Schneider, R., Amir, G., Condiotti, R., Heikenwalder, M., Weber, A., Schramm, C., Wege, H., Kluwe, J., Galun, E., & Giladi, H. (2016). Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia. GASTROENTEROLOGY, 151(5), 999-1010.e3. https://doi.org/10.1053/j.gastro.2016.07.031

Vancouver

Bibtex

@article{77eeadd563d249f79a8600ba38e1d3e9,
title = "Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia",
abstract = "BACKGROUND & AIM: Anemia is commonly associated with acute and chronic inflammation, but the mechanisms of their interaction are not clear. We investigated whether microRNA 122 (MIR122), which is generated in the liver and is secreted into the blood, is involved in the development of anemia associated with inflammation.METHODS: We characterized the primary transcript of the human liver-specific MIR122 using northern blot, quantitative real-time PCR, and 3' and 5' RACE analyses. We studied regulation of MIR122 in human hepatocellular carcinoma (HCC) cell lines (Huh7 and HepG2) as well as in C57BL/6 and mice with disruption of the tumor necrosis factor gene (Tnf). Liver tissues were collected and analyzed by bioluminescence imaging or immunofluorescence. Inflammation in mice was induced by lipopolysaccharide (LPS) or by cerulein injections. Mice were given 4 successive injections of LPS, leading to inflammation-induced anemia. Steatohepatitis was induced with a choline-deficient high-fat diet. Hemolytic anemia was stimulated by phenylhydrazine injection. MIR122 was inhibited in mice by tail-vein injection of antogomiR-122 (an oligonucleotide antagonist of MIR122). MicroRNA and mRNA levels were determined by quantitative real time PCR.RESULTS: The primary transcript of MIR122 spanned 5 kb, comprising 3 exons; the third encodes MIR122. Within the MIR122 promoter region we identified a nuclear factor-κB (NF-κB) binding site and demonstrated that RELA, as well as activators of NF-κB (TNF and LPS), increased promoter activity of MIR122. Administration of LPS to mice induced secretion of MIR122 into blood, which required TNF. Secreted MIR122 reached the kidney and reduced expression of erythropoietin (Epo), which we identified as a MIR122 target gene. Injection of mice with antagomiR-122 increased blood levels of EPO, reticulocytes, and hemoglobin. We found an inverse relationship between blood levels of MIR122 and EPO in mice with acute pancreatitis or steatohepatitis, and also in patients with acute inflammation.CONCLUSION: In mice, we found that LPS-induced inflammation increases blood levels of MIR122, which reduces expression of Epo in the kidney; this is a mechanism of inflammation-induced anemia. Strategies to block MIR122 in patients with inflammation could reduce the development or progression of anemia.",
author = "Mila Rivkin and Alina Simerzin and Elina Zorde-Khvalevsky and Chofit Chai and Yuval, {Jonathan B} and Nofar Rosenberg and Rona Harari-Steinfeld and Ronen Schneider and Gail Amir and Reba Condiotti and Mathias Heikenwalder and Achim Weber and Christoph Schramm and Henning Wege and Johannes Kluwe and Eithan Galun and Hilla Giladi",
note = "Copyright {\textcopyright} 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.",
year = "2016",
month = nov,
doi = "10.1053/j.gastro.2016.07.031",
language = "English",
volume = "151",
pages = "999--1010.e3",
journal = "GASTROENTEROLOGY",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia

AU - Rivkin, Mila

AU - Simerzin, Alina

AU - Zorde-Khvalevsky, Elina

AU - Chai, Chofit

AU - Yuval, Jonathan B

AU - Rosenberg, Nofar

AU - Harari-Steinfeld, Rona

AU - Schneider, Ronen

AU - Amir, Gail

AU - Condiotti, Reba

AU - Heikenwalder, Mathias

AU - Weber, Achim

AU - Schramm, Christoph

AU - Wege, Henning

AU - Kluwe, Johannes

AU - Galun, Eithan

AU - Giladi, Hilla

N1 - Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

PY - 2016/11

Y1 - 2016/11

N2 - BACKGROUND & AIM: Anemia is commonly associated with acute and chronic inflammation, but the mechanisms of their interaction are not clear. We investigated whether microRNA 122 (MIR122), which is generated in the liver and is secreted into the blood, is involved in the development of anemia associated with inflammation.METHODS: We characterized the primary transcript of the human liver-specific MIR122 using northern blot, quantitative real-time PCR, and 3' and 5' RACE analyses. We studied regulation of MIR122 in human hepatocellular carcinoma (HCC) cell lines (Huh7 and HepG2) as well as in C57BL/6 and mice with disruption of the tumor necrosis factor gene (Tnf). Liver tissues were collected and analyzed by bioluminescence imaging or immunofluorescence. Inflammation in mice was induced by lipopolysaccharide (LPS) or by cerulein injections. Mice were given 4 successive injections of LPS, leading to inflammation-induced anemia. Steatohepatitis was induced with a choline-deficient high-fat diet. Hemolytic anemia was stimulated by phenylhydrazine injection. MIR122 was inhibited in mice by tail-vein injection of antogomiR-122 (an oligonucleotide antagonist of MIR122). MicroRNA and mRNA levels were determined by quantitative real time PCR.RESULTS: The primary transcript of MIR122 spanned 5 kb, comprising 3 exons; the third encodes MIR122. Within the MIR122 promoter region we identified a nuclear factor-κB (NF-κB) binding site and demonstrated that RELA, as well as activators of NF-κB (TNF and LPS), increased promoter activity of MIR122. Administration of LPS to mice induced secretion of MIR122 into blood, which required TNF. Secreted MIR122 reached the kidney and reduced expression of erythropoietin (Epo), which we identified as a MIR122 target gene. Injection of mice with antagomiR-122 increased blood levels of EPO, reticulocytes, and hemoglobin. We found an inverse relationship between blood levels of MIR122 and EPO in mice with acute pancreatitis or steatohepatitis, and also in patients with acute inflammation.CONCLUSION: In mice, we found that LPS-induced inflammation increases blood levels of MIR122, which reduces expression of Epo in the kidney; this is a mechanism of inflammation-induced anemia. Strategies to block MIR122 in patients with inflammation could reduce the development or progression of anemia.

AB - BACKGROUND & AIM: Anemia is commonly associated with acute and chronic inflammation, but the mechanisms of their interaction are not clear. We investigated whether microRNA 122 (MIR122), which is generated in the liver and is secreted into the blood, is involved in the development of anemia associated with inflammation.METHODS: We characterized the primary transcript of the human liver-specific MIR122 using northern blot, quantitative real-time PCR, and 3' and 5' RACE analyses. We studied regulation of MIR122 in human hepatocellular carcinoma (HCC) cell lines (Huh7 and HepG2) as well as in C57BL/6 and mice with disruption of the tumor necrosis factor gene (Tnf). Liver tissues were collected and analyzed by bioluminescence imaging or immunofluorescence. Inflammation in mice was induced by lipopolysaccharide (LPS) or by cerulein injections. Mice were given 4 successive injections of LPS, leading to inflammation-induced anemia. Steatohepatitis was induced with a choline-deficient high-fat diet. Hemolytic anemia was stimulated by phenylhydrazine injection. MIR122 was inhibited in mice by tail-vein injection of antogomiR-122 (an oligonucleotide antagonist of MIR122). MicroRNA and mRNA levels were determined by quantitative real time PCR.RESULTS: The primary transcript of MIR122 spanned 5 kb, comprising 3 exons; the third encodes MIR122. Within the MIR122 promoter region we identified a nuclear factor-κB (NF-κB) binding site and demonstrated that RELA, as well as activators of NF-κB (TNF and LPS), increased promoter activity of MIR122. Administration of LPS to mice induced secretion of MIR122 into blood, which required TNF. Secreted MIR122 reached the kidney and reduced expression of erythropoietin (Epo), which we identified as a MIR122 target gene. Injection of mice with antagomiR-122 increased blood levels of EPO, reticulocytes, and hemoglobin. We found an inverse relationship between blood levels of MIR122 and EPO in mice with acute pancreatitis or steatohepatitis, and also in patients with acute inflammation.CONCLUSION: In mice, we found that LPS-induced inflammation increases blood levels of MIR122, which reduces expression of Epo in the kidney; this is a mechanism of inflammation-induced anemia. Strategies to block MIR122 in patients with inflammation could reduce the development or progression of anemia.

U2 - 10.1053/j.gastro.2016.07.031

DO - 10.1053/j.gastro.2016.07.031

M3 - SCORING: Journal article

C2 - 27477940

VL - 151

SP - 999-1010.e3

JO - GASTROENTEROLOGY

JF - GASTROENTEROLOGY

SN - 0016-5085

IS - 5

ER -